Global Parkinson’s Disease Market Report: 2016 Edition - New Report by Koncept Analytics - PowerPoint PPT Presentation

Loading...

PPT – Global Parkinson’s Disease Market Report: 2016 Edition - New Report by Koncept Analytics PowerPoint presentation | free to download - id: 813c2a-YTIyM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Parkinson’s Disease Market Report: 2016 Edition - New Report by Koncept Analytics

Description:

The report, “Global Parkinson’s disease Market” analyzes the currently prevailing condition of the market. For details, write to info@daedal-research.com – PowerPoint PPT presentation

Number of Views:11

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Parkinson’s Disease Market Report: 2016 Edition - New Report by Koncept Analytics


1
Global Parkinsons Disease Market Report
----------------------------------------- 2016
View Report Details
2
View Report Details
  • Executive Summary
  • Parkinsons Disease (PD) is a chronic and
    progressive neurodegenerative or movement
    disorder which involves the malfunction and death
    of vital nerve cells in the brain, called
    neurons. Parkinsons primarily affects neurons in
    an area of the brain called the substantia
    nigra. The early signs and symptoms may be mild
    and may go unnoticed initially. The cause of this
    disease is mainly unknown with no cure till date
    but there exist several treatment options such as
    medications and surgery.
  • The current treatment market for Parkinsons
    disease has several unmet needs as no treatment
    has yet been successful in fully restoring the
    function that produces dopamine. However, the
    treatment currently only aims at controlling and
    relieving symptoms. The Parkinsons disease
    treatment market remains flooded by both branded
    and generic drugs. The market is expected to
    experience fluctuations in branded sales due to
    patent expiries and subsequent entry of generics
    in the market. Several biologics are under
    development for the treatment of Parkinsons
    along with possibility of developing Stem Cell
    as a treatment therapy.
  • The Parkinsons disease market is expected to
    acquire modest growth driven by launch of new
    therapies and increasing rate of drug treatment
    due to increasing healthcare expenditure and
    ageing population. The major growth drivers of
    the Parkinsons disease market includes rising
    level of toxin exposure, increasing life
    expectancy, rising male population worldwide,
    ageing population, healthcare expenditure and
    pesticide consumption. However, the growth of the
    market will also remain challenged by generic
    erosion, current treatment limitations and
    increasing risk of developing Melanoma.
  • The report, Global Parkinsons disease Market
    analyzes the currently prevailing condition of
    the market along with its future scope of
    development. The specific markets of the U.S.,
    the European Union and Japan are being discussed
    in the report. The major trends, growth drivers
    as well as issues being faced by the industry are
    being presented in this report. The major players
    in the industry are being profiled, along with
    their key financials and strategies for growth.

3
Growth of the Parkinsons disease drug market is
expected to be primarily driven by several
factors inclusive of increasing Parkinsons
disease prevalence, rise in ageing population
globally and increasing cost of treatment
therapies
Global Parkinsons Disease Drug Market by Value
(2010-2015E)
  • The global Parkinsons disease drug market is
    estimated to have reached US... billion in the
    year 2015, increasing from US... billion in the
    previous fiscal year recording an annual growth
    of .
  • The European Union accounted for the maximum
    share of in revenue of the global Parkinsons
    disease drug market for the year 2014. The U.S.
    accounted for second largest share of followed
    by Japan that held share.
  • Both Dopamine agonists and COMT inhibitors are
    estimated to have held equal share of for the
    year 2015, followed by MAO inhibitors and
    Levodopa with expected share of and .
    respectively.

Global Parkinsons Disease Drug Market by Region
(2014)
Global Parkinsons Disease Market by Drug Class
(2015E)
4
The Parkinsons disease market in the U.S. has
high unmet needs in safety and efficacy, thus,
significantly suggesting that currently the
market is still served below par by the existing
treatment options
The U.S. Parkinsons Disease Market by Value
Volume (2013-2020E)
  • The U.S. Parkinsons disease market reached
    US... million in the year 2015, with a further
    estimation of reaching US... million by the end
    of year 2020. In terms of prescription volume the
    market reached million in the year 2015.
  • Both branded and generic drugs in the U.S. held
    equal share of of the overall revenue for the
    year 2015. The revenue share of generics will
    keep declining by the end of year 2017, recording
    an expected share of ...
  • In 2015, majority of the Parkinsons patients in
    the U.S. were treated with MAO-Inhibitors with
    share of the total market followed by
    Levodopa/Carbidopa (gold standard) holding
    share.

The U.S. Parkinsons Disease Market Value by
Category (2013-2017E)
The U.S. Parkinsons Disease Market by Drug Class
(2015)
5
The Parkinsons Disease treatment market can
acquire modest growth in the coming years driven
by the launch of new therapies and increasing
drug treatment rates due to increasing healthcare
expenditure and ageing population
The U.S. Parkinsons Branded Drugs Market by
Volume/ Value (2013-2020E)
  • The Parkinsons disease branded drugs market of
    the U.S. reached US.. million in 2015,
    increasing from US... million in the previous
    year recording an annual growth of . In terms
    of volume, the market reached million
    prescriptions decreasing from .. million in the
    previous fiscal year.
  • The drug market for Parkinsons disease in the EU
    (Germany, France, the UK, Italy and Spain)
    reached US... million declining from US...
    million in the previous fiscal year.
  • The Parkinsons disease market of Japan reached
    US... million in the year 2015, increasing from
    US... million in the previous fiscal year
    recording an annual growth of .

European Parkinsons Disease Drug Market by Value
(2014/2015)
Japans Parkinsons Disease Drug Market by Value
(2014/2015)
6
Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Parkinsons Disease Market . To know more about
this report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com
About PowerShow.com